Dayton M T, Traverso L W, Longmire W P
Arch Surg. 1980 Sep;115(9):1086-9. doi: 10.1001/archsurg.1980.01380090054013.
To evaluate the efficacy of the gallbladder as an alternate drainage route in biliary obstruction, we reviewed the charts of 79 patients who underwent 80 cholecystoenterostomy (CCE) procedures at the UCLA Hospital during the period between 1955 and 1978. Among these procedures, 62 (77.5%) were done for malignant obstruction and 18 (22.5%) for benign obstruction; three patients with malignancy and one with benign disease were unavailable for follow-up. The CCE procedure failed in nine patients (11.8), five of 59 cases involving malignancy (8.5%), and four of 17 (23.5%) for benign disease. The 26-month cumulative patency was found to be 78.9% in malignant disease and 68.6% in benign disease. The combined failure rate of cholecystojejunostomy was 8.3%, compared to 30.8% with cholecystoduodenostomy. "Gross inflammation" was the only variable predictive of future CCE failure. The study suggests that CCE should be used primarily in terminal malignancy when a simple, short-term biliary bypass is desired.
为评估胆囊作为胆道梗阻替代引流途径的疗效,我们回顾了1955年至1978年期间在加州大学洛杉矶分校医院接受80例胆囊肠吻合术(CCE)的79例患者的病历。在这些手术中,62例(77.5%)用于恶性梗阻,18例(22.5%)用于良性梗阻;3例恶性肿瘤患者和1例良性疾病患者无法进行随访。CCE手术在9例患者(11.8%)中失败,59例恶性肿瘤病例中有5例(8.5%),17例良性疾病中有4例(23.5%)。发现恶性疾病的26个月累积通畅率为78.9%,良性疾病为68.6%。胆囊空肠吻合术的联合失败率为8.3%,而胆囊十二指肠吻合术为30.8%。“严重炎症”是唯一可预测未来CCE失败的变量。该研究表明,当需要简单、短期的胆道旁路时,CCE应主要用于终末期恶性肿瘤。